Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Sees Significant Growth in Short Interest

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the recipient of a significant growth in short interest in the month of September. As of September 30th, there was short interest totalling 19,700 shares, a growth of 1,213.3% from the September 15th total of 1,500 shares. Based on an average daily trading volume, of 4,800 shares, the short-interest ratio is presently 4.1 days.

Cardio Diagnostics Stock Performance

Shares of NASDAQ CDIOW opened at $0.04 on Friday. Cardio Diagnostics has a 1-year low of $0.02 and a 1-year high of $0.28. The business’s 50 day moving average is $0.04 and its 200-day moving average is $0.05.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.